No Data
6 Analysts Have This To Say About Encompass Health
6 analysts have expressed a variety of opinions on Encompass Health (NYSE:EHC) over the past quarter, offering a diverse set of opinions from bullish to bearish.The table below offers a condensed view
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Price Target Raised to $95.00/Share From $83.00 by RBC Capital
Encompass Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/22/2024 10.77% RBC Capital $83 → $95 Maintains Outperform 04/26/2024 10.77% Raymond James $85 → $95 Rei
Encompass Health (EHC) Gets a Buy From RBC Capital
RBC Lifts Price Target on Encompass Health to $95 From $83, Cites 'Strong' Q1 Results, 2024 Guidance Boost; Outperform Kept
Encompass Health (EHC) has an average investment rating of buy among analysts polled by Capital IQ, with price targets ranging from $94 to $108.
Express News | Encompass Health Corp : RBC Raises Target Price to $95 From $83